Clinical trial
Combination Chemotherapy and Celecoxib in Treating Patients With Advanced…
NCT00073866 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00073866 |
|---|---|
| Title | Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer |
| Official title | Phase I/II Trial Of Weekly Irinotecan And Docetaxel With The Addition Of Celecoxib In Advanced Non-Small Cell Lung Cancer |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | celecoxib, docetaxel, irinotecan hydrochloride |
| Start date | Jun 1, 2003 |
| Primary completion | Dec 1, 2004 |
| Completion | Dec 1, 2004 |
| First posted | Dec 11, 2003 |
| Last update posted | Jul 19, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: